As per the report published by Fior Markets, the global cytomegalovirus treatment market is expected to grow from USD xx Million in 2017 to USD xx Million by 2025 at a CAGR of xx during the forecast period from 2018-2025. North America is estimated to dominate the market in the forecast period. Government support for quality healthcare, high purchasing power, availability of reimbursement, and increasing prevalence of cancers in the region are some of the major factors driving the growth of the market.

Global Cytomegalovirus Treatment Market by Drug Type (Cidofovir, Foscarnet, Valganciclovir, Ganciclovir), Infection Type, Distribution Channel, and Region” and Global Forecast 2018-2025.


Prominent player soperating in the market are Merck & Co. Inc., Cell Medical Ltd., Chimerix, Inc., Affymetrix, Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd. and others.Competitors are developing new technologies to retain their foothold in the global market. For instance, in 2017, Merck & Co., Inc. started pivotal Phase 3 clinical study of letermovir. It is an antiviral investigational drug for treating clinically significant cytomegalovirus Infection. In January 2018, Shire received FDA approval for its Breakthrough Therapy Designation to maribavir. It is company’s Phase III investigational drug for the treatment of cytomegalovirus (CMV) infections,which is resistant to prior therapy. If approved, maribavir will join Prevymis in boosting the CMV therapeutics landscape after almost two decades of relative stasis.

Drug type is classified intocidofovir, foscarnet, valganciclovir, and ganciclovir. These are few of the most prescribed medication for the treatment of cytomegalovirus. Infection type includes retinitis, pneumonia, gastrointestinal ulcers, encephalitis and others.Distribution channel is divided into hospital pharmacies, retail pharmacies and online pharmacies. Hospital pharmacies are driving the market due to the easy availability of medication and increasing prescription patterns for the treatment of CMV.


Prominent players in the market are investing in R&D for the development of novel therapies and drugs to treat CMV infection. In additionregulatory bodies are giving more attention to novel drugs by giving faster approvalsis also driving the market.Limited options of the treatment is restraining thegrowth of the market. However, increasing awareness related to herpes virus infections boosting the market growth.

Customization of the Report:This report can be customized to meet the client’s requirements. Please connect with our sales team(,who will ensure that you get a report that suits your needs.